Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25361992

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2015 Jan
First author
Cella D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Cella D
      type
      Author
    2. name
      Ivanescu C
      type
      Author
    3. name
      Holmstrom S
      type
      Author
    4. name
      Bui CN
      type
      Author
    5. name
      Spalding J
      type
      Author
    6. name
      Fizazi K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Cella D
      type
      Author
    2. name
      Ivanescu C
      type
      Author
    3. name
      Holmstrom S
      type
      Author
    4. name
      Bui CN
      type
      Author
    5. name
      Spalding J
      type
      Author
    6. name
      Fizazi K
      type
      Author
    bibliography ids
    1. nci-bib-927602ec0c4d435dbcc79ce6
    book metadata
    content sha256
    7e32b23f4d0f5d808c8de43302770b095d55d0cc71108042f089581e5ac04363
    document type
    citation
    dois
    1. 10.1093/annonc/mdu510
    electronic publication date
    display
    2014 Oct 30
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25361992
    immutable id
    pubmed:25361992@7e32b23f4d0f5d808c8de43302770b095d55d0cc71108042f089581e5ac04363
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    1
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    179-185
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25361992
      provenance
      batch id
      863b068fe5a07222af6a
      provider
      NCBI PubMed ESummary
      record sha256
      47383fdbf83d7a47edd0fc2edb8e1e7c2ccf0778aa63173d544d5bc8645051be
      response sha256
      80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
      retrieved at
      2026-09-09T23:47:07.648963+00:00
      publication date
      display
      2015 Jan
      precision
      month
      year
      2015
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25361992/
      title
      Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial.

      Preserved source evidence · Not medical advice